Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital de Rangueil

Toulouse 31400

1 studies enrolling now · 3 studies all time

What they study most

Antibody-mediated Rejection, Microvascular Inflammation

Studies at this site

• A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation — Recruiting now
• A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR) — Running, not enrolling
• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) — Running, not enrolling